Ethanol extract of Inonotus obliquus inhibits lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells

Journal of Medicinal Food

Volumn 10, Issue 1, 2007, Pages 80-89

  Kim, Ho Gyoung ^a,b   Yoon, Deok Hyo ^a   Kim, Chun Hoi ^a   Shrestha, Bhushan ^a,e   Chang, Woo Chul ^d   Lim, So Yeon ^d   Lee, Won Ho ^a   Han, Sang Guk ^a   Lee, Je O ^a   Lim, Mi Hee ^a   Kim, Geun Young ^a   Choi, Sunga ^c   Song, Won O ^f   Sung, Jae Mo ^a   Hwang, Ki Chul ^d   Kim, Tae Woong ^a  

^a Kangwon National University   (South Korea)

^b Mushtech Co Ltd   (South Korea)

^c Hallym University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Green Energy Mission/Nepal   (Nepal)

^f Michigan State University   (United States)

Author keywords

Akt; Anti inflammation; Antioxidant; Inonotus obliquus; Mitogen activated protein kinases; RAW 264.7 macrophage cells

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INONOTUS OBLIQUUS EXTRACT; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B BETA; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BASIDIOMYCOTA; CELL LINE; CYCLOOXYGENASE 2 INHIBITORS; ENZYME INHIBITORS; ETHANOL; GENE EXPRESSION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; RNA, MESSENGER;

BASIDIOMYCOTA; FUNGI; HYMENOCHAETACEAE; INONOTUS OBLIQUUS;

EID: 34248216448     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.156     Document Type: Article

References (37)

1. Campbell WA, Davidson RW: A Poria as the fruiting stage of the fungus causing the sterile conks on birch. Mycologia 1938; 30:553-560.
2. Kahlos K, Hiltunen R: Identification of some lanostane type triterpenes from Inonotus obliquus. Acta Pharm Fenn 1983;92: 220-224.
3. Shivrina AN: Chemical characteristics of compounds extracted from Inonotus obliquus. Chem Abstr 1967;66:17271-17279.
4. Loviagina EV, Shivrina AN: In steroid compound of the Chaga fungus. Biobimija 1962;27:794-800.
5. Shin YS, Minoru T, Cho NS: Chemical constituent of stationary mycelia of Inonotus obliquus. Mokchae Konghak 2004;32:52-57.
6. Ham SS, Oh SW, Kim YK, Shin KS, Chang HY, Chung GH: Antimutagenic and cytotoxic effects of ethanol extract from the Inonotus obliquus. J Korean Soc Food Sci Nutr 2003;32:1088-1094.
7. Cha JY, Jeon BS, Moon JC, Yoo JH, Cho YS: Cytotoxic effect of Inonotus obliquus composition in HCT-15 human colon cancer cells and AGS gastric cancer cells. J Korean Soc Food Sci Nutr 2004;33:633-640.
8. Kahlos K, Kangas L, Hitunen R: Antitumor activity of some coinpounds and fractions from an n-hexane extract of Inonotus obliquus. Acta Pharm Fenn 1987;96:33-40.
9. Mizuno T, Zhuang C, Abe K, Okamoto H, Kiho T, Ukai S, Leclerc S, Meijer L: Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus (Pers.: Fr.) Pil. (Aphyllophoromycetideae). Int J Med Mushrooms 1999;1:301-316.
10. Cui Y, Kim DS, Park KC: Antioxidant effect of Inonotus obliquus. J Ethnopharmacol 2005;96:79-85.
11. Song HS, Lee YJ, Kim SK, Moon WK, Kim DW, Kim YS, Moon KY: Downregulatory effect of AGI-1120 (α-glucosidase inhibitor) and Chaga mushroom (Inonotus obliquus) on cellular NFκB activation and their antioxidant activity. Korean J Pharmacogen 2004;35:92-97.
12. Kim YO, Han SB, Lee HW, Ahn HJ, Yoon YD, Jung JK, Kim HM, Shin CS: Immuno-stimulating effect of the endo-polysaccharide produced by submerged culture of Inonotus obliquus. Life Sci 2005;77:2438-2456.
13. Park YM, Won JH, Kim YH, Choi JW, Park HJ, Lee KT: In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus. J Ethnopharmacol 2005; 101:120-128.
14. D'Acquisto F, May MJ, Ghosh S: Inhibition of nuclear factor kappa B (NF-κB): an emerging theme in anti-inflammatory therapies. Mol Interv 2002;2:22-35.
15. Tak PP, Firestein GS: NF-κB: a key role in inflammatory diseases. J Clin Invest 2001;107:7-11.
16. Tergaonkar V: NFκB pathway: a good signaling paradigm and therapeutic target. Int J Biochem Cell Biol 2006;38:1647-1653.
17. Moynagh PN: The NF-κB pathway. J Cell Sci 2005;118: 4389-4392.
18. Pan MH, Lin-Shiau SY, Lin JK: Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol 2000;60:1665-1676.
19. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB: NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999;401:82-85.
20. Kim YH, Choi KH, Park JW, Kwon TK: LY294002 inhibits LPS-induced NO production through a inhibition of NF-kappaB activation: independent mechanism of phosphatidylinositol 3-kinase. Immunol Lett 2005;99:45-50.
21. Kaminska B: MAPK signaling pathways as molecular targets for anti-inflammatory therapy - from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 2005;1754:253-262.
22. Paul A, Cuenda A, Bryant CE, Murray J, Chilvers ER, Cohen P, Gould GW, Plevin R: Involvement of mitogen-activated protein kinase homologues in the regulation of lipopolysaccharide-mediated induction of cyclo-oxygenase-2 but not nitric oxide synthase in RAW 264.7 macrophages. Cell Signal 1999;11:491-497.
23. Chen TH, Kao YC, Chen BC, Chen CH, Chan P, Lee HM: Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells. Eur J Pharmacol 2006;541:138-146.
24. Uto T, Fujii M, Hou DX: 6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide-activated murine macrophages. Biochem Pharmacol 2005;70:1211-1221.
25. Chen CC, Wang JK: p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol Pharmacol 1999;55:481-488.
26. Kim BC, Choi JW, Hong HY, Lee SA, Hong S, Park EH, Kim SJ, Lim CJ: Heme oxygenase-1 mediates the anti-inflammatory effect of mushroom Phellinus linteus in LPS-stimulated RAW264.7 macrophages. J Ethnopharmacol 2006;106:364-371.
27. Kim KM, Kwon YG, Chung HT, Yun YG, Pae HO, Han JA, Ha KS, Kim TW, Kim YM: Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-kappaB activation. Toxicol Appl Pharmacol 2003;190:1-8.
28. Abreu P, Matthew S, Gonzalez T, Costa D, Segundo MA, Fernandes E: Anti-inflammatory and antioxidant activity of a medicinal tincture from Pedilanthus tithymaloides. Life Sci 2006; 78:1578-1585.
29. Guha M, Mackman N: LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85-94.
30. Berenbaum F: Proinflammatory cytokines, prostaglandins, and the chondrocyte: mechanisms of intracellular activation. Joint Bone Spine 2000;67:561-564.
31. Kim JH, Kim DH, Baek SH, Lee HJ, Kim MR, Kwon HJ, Lee CH: Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-kappaB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells. Biochem Pharmacol 2006;71:1198-1205.
32. Jeon YJ, Kim YK, Lee M, Park SM, Han SB, Kim HM: Radicicol suppresses expression of inducible nitric-oxide synthase by blocking p38 kinase and nuclear factor-kappaB/Rel in lipopolysaccharide-stimulated macrophages. J Pharmacol Exp Ther 2000;294:548-554.
33. Hou DX, Yanagita T, Uto T, Masuzaki S, Fujii M: Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanisms involved. Biochem Pharmacol 2005;70:417-425.
34. Hsu HY, Wen MH: Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 2002;277:22131-22139.
35. Zhang B, Hirahashi J, Cullere X, Mayadas TN: Redox signaling and the MAP kinase pathways. Biofactors 2003;17:287-296.
36. 2 on the receptor tyrosine kinases, the MAP kinase cascade, and IKappaB kinases. Ann N Y Acad Sci 2002;973:419-422.
37. Babitskaia VG, Shcherba VV, Ikonnikova NV: Melanin complex of the fungus Inonotus obliquus. Prikl Biokhim Mikrobiol 2000; 36:439-444.